Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome

Prenatal Diagnosis

Volumn 26, Issue 9, 2006, Pages 842-849

  Craig, Wendy Y ^a   Haddow, James E ^a,b   Palomaki, Glenn E ^b   Kelley, Richard I ^c   Kratz, Lisa E ^c   Shackleton, Cedric H L ^d   Marcos, Josep ^d   Stephen Tint, G ^e   MacRae, Andrew R ^f   Nowaczyk, Malgorzata J ^g   Kloza, Edward M ^a   Irons, Mira B ^h   Roberson, Marie ⁱ  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

^f LAKERIDGE HEALTH CORPORATION   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ STATE OF CALIFORNIA   (United States)

Author keywords

Diagnostic testing; Prenatal screening; Prevalence; Smith Lemli Opitz syndrome

Indexed keywords

STEROID;

ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS DEATH; FETUS ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SMITH LEMLI OPITZ SYNDROME; STEROID URINE LEVEL;

ABNORMALITIES, MULTIPLE; ADULT; ALGORITHMS; AMNIOCENTESIS; BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; GENETIC SCREENING; GENETIC TESTING; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREVALENCE; SMITH-LEMLI-OPITZ SYNDROME; STEROIDS; UNITED STATES;

EID: 33749459449     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1518     Document Type: Article

References (20)

1. Abuelo DN, Tint GS, Kelley R, et al. 1995. Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols. Am J Med Genet 56: 281-285.
2. Blitzer MG, Kelley RI, Schwartz MF. 1994. Abnormal maternal serum marker pattern associated with Smith-Lemli-Opitz syndrome. Am J Hum Genet 55: A277.
3. Bradley LA, Palomaki GE, Knight GJ, et al. 1999. Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Genet 82: 355-358.
4. Canick JA, Abuelo DN, Bradley LA, Tint GS. 1997. Maternal serum marker levels in two pregnancies affected with Smith-Lemli-Opitz syndrome. Prenat Diagn 17: 187-189.
5. Hyett JA, Clayton PT, Moscoso G, Nicolaides KH. 1995. Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 58: 374-376.
6. Kelley RI. 1995. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta 236: 45-58.
7. Kelley RI. 1997. A new face for an old syndrome. Am J Med Genet 68: 251-256.
8. Kelley RI, Hennekam RC. 2000. The Smith-Lemli-Opitz syndrome. J Med Genet 37: 321-335.
9. Kelley RI, Herman GE. 2001. Inborn errors of sterol biosynthesis. Annu Rev Genomics Hum Genet 2: 299-341.
10. Kratz LE, Kelley RI. 1999. Prenatal diagnosis of the RSH/Smith-Lemli- Opitz syndrome. Am J Med Genet 82: 376-381.
11. Lykkesfeldt G, Nielsen MD, Lykkesfeldt AE. 1984. Placental steroid sulfatase deficiency: biochemical diagnosis and clinical review. Obstet Gynecol 64: 49-54.
12. Nowaczyk MJ, Zeesman S, Waye JS, Douketis JD. 2004. Incidence of Smith-Lemli-Opitz syndrome in Canada: results of three-year population surveillance. J Pediatr 145: 530-535.
13. Palomaki GE, Bradley LA, Knight GJ, Craig WY, Haddow JE. 2002. Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen 9: 43-44.
14. Rossiter JP, Hofman KJ, Kelley RI. 1995. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. Am J Med Genet 56: 272-275.
15. Ryan AK, Bartlett K, Clayton P, et al. 1998. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet 35: 558-565.
16. Schoen E, Norem C, O'Keefe J, et al. 2003. Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions. Obstet Gynecol 102: 167-172.
17. Shackleton CH, Roitman E, Kratz L, Kelley R. 2001. Dehydrooestriol and dehydropregnanetriol are candidate analytes for prenatal diagnosis of Smith-Lemli-Opitz syndrome. Prenat Diagn 21: 207-212.
18. Shinawi M, Szabo S, Popek E, et al. 2005. Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol. Am J Med Genet A 138: 56-60.
19. Smith DW, Lemli L, Opitz JM. 1964. A newly recognized syndrome of multiple congenital anomalies. J Pediatr 64: 210-217.
20. Tint GS, Irons M, Elias ER, et al. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330: 107-113.